Hemoprostol: Opinion on medicine for use outside EU

misoprostol

Table of contents

Opinion on medicine for use outside the European Union
Withdrawn opinion

Overview

The opinion for Hemoprostol for use outside the European Union has been withdrawn at the request of the opinion holder.

Opinion details

Product details
Name of medicinal product
Hemoprostol
Agency opinion number
H-W-2652
Opinion status
Withdrawn opinion
Active substance
misoprostol
International non-proprietary name (INN) or common name
misoprostol
Therapeutic area (MeSH)
Postpartum Hemorrhage
Anatomical therapeutic chemical (ATC) code
G02AD06
Publication details
Opinion holder

Linepharma International Limited
Regents Place
338 Euston Road
London NW1 3BT
United Kingdom
Date of opinion
23/01/2014

Product information

26/03/2015 Hemoprostol H-W-2652-IAIN-0003

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Other gynecologicals

Therapeutic indication

Hemoprostol is indicated in women of childbearing age for treatment of Post Partum Haemorrhage due to uterine atony in situations where intravenous oxytocin is not available.

Assessment history

How useful was this page?

Add your rating